Press release
Catheter Related Bloodstream Infections Market Predicted to See Upsurge Through 2034, Highlights DelveInsight | Xellia Pharma, Pfizer, Glenmark Pharma, Fresenius Medical Care
To Know in detail about the Catheter Related Bloodstream Infections market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Catheter Related Bloodstream Infections Market Forecast
https://www.delveinsight.com/sample-request/catheter-related-bloodstream-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Catheter Related Bloodstream Infections Market Report:
• The Catheter Related Bloodstream Infections market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
• In November 2024, Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) ("Citius Pharma" or the "Company"), a biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, announced today that it held a productive in-person Type C meeting with the U.S. Food and Drug Administration (FDA). This meeting took place after the successful completion of the Company's pivotal Phase 3 clinical trial for Mino-Lok®, a novel catheter lock solution aimed at salvaging central venous catheters in patients with central line-associated bloodstream infections (CLABSI) or catheter-related bloodstream infections (CRBSI). The main discussion focused on the FDA's questions regarding Mino-Lok's clinical trial data and the potential pathway for future submission.
• In May 2024, Citius Pharmaceuticals reported positive topline results from its pivotal Phase III clinical trial of Mino-Lok. The study achieved its primary endpoint, showing a statistically significant improvement in time to failure events in patients treated with Mino-Lok compared to those in the control group receiving clinician-directed anti-infective lock solutions.
• As per the DelveInsight's estimates, the total incident population of CRBSI in the 7MM was found to be around 674,000 in 2020, which is anticipated to increase in the forecasted period
• The estimates show a higher incidence of Catheter Related Bloodstream Infections in the US with about 331,000 cases in 2020
• As per the analysis, in the US, the incidence of Gram-positive bacteria is more than Gram negative bacteria and very few are affected with candida species (fungi)
• Among EU4 and the UK, Germany accounted for the highest incident cases of Catheter Related Bloodstream Infections with more than 62,000 cases in 2020. Whereas, the least number of incident cases was contributed by Spain with about 17,000 cases
• Key Catheter Related Bloodstream Infections Companies: CorMedix, Xellia Pharmaceuticals Ltd., Pfizer, Glenmark Pharmaceuticals Ltd., Fresenius Medical Care, CorMedix, Inc., TauroPhar GmbH, Geistlich Pharma, Citus Pharmaceuticals, AstraZeneca, Merck & Co., Inc., and others
• Key Catheter Related Bloodstream Infections Therapies: DEFENCATH, Mino-Lok, Neutrolin, Daptomycin, Linezolid, and others
• The Catheter Related Bloodstream Infections epidemiology based on gender analyzed that the incidence of Catheter Related Bloodstream Infections is found to be prominent in Non-ICU settings
• The Catheter Related Bloodstream Infections market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Catheter Related Bloodstream Infections pipeline products will significantly revolutionize the Catheter Related Bloodstream Infections market dynamics.
Catheter Related Bloodstream Infections Overview
Catheter-related bloodstream infection (CRBSI) is defined as the presence of bacteremia originating from an intravenous catheter. It is one of the most frequent, lethal, and costly complications of central venous catheterization and also the most common cause of nosocomial bacteremia.
Get a Free sample for the Catheter Related Bloodstream Infections Market Report:
https://www.delveinsight.com/report-store/catheter-related-bloodstream-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Catheter Related Bloodstream Infections Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Catheter Related Bloodstream Infections Epidemiology Segmentation:
The Catheter Related Bloodstream Infections market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Catheter Related Bloodstream Infections
• Prevalent Cases of Catheter Related Bloodstream Infections by severity
• Gender-specific Prevalence of Catheter Related Bloodstream Infections
• Diagnosed Cases of Episodic and Chronic Catheter Related Bloodstream Infections
Download the report to understand which factors are driving Catheter Related Bloodstream Infections epidemiology trends @ Catheter Related Bloodstream Infections Epidemiology Forecast
https://www.delveinsight.com/sample-request/catheter-related-bloodstream-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Catheter Related Bloodstream Infections Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Catheter Related Bloodstream Infections market or expected to get launched during the study period. The analysis covers Catheter Related Bloodstream Infections market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Catheter Related Bloodstream Infections Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Catheter Related Bloodstream Infections Therapies and Key Companies
• DEFENCATH: CorMedix
• Mino-Lok: Citius Pharmaceutical
• Neutrolin: CorMedix
• Daptomycin: Cubist Pharma
• Linezolid: Pfizer
Discover more about therapies set to grab major Catheter Related Bloodstream Infections market share @ Catheter Related Bloodstream Infections Treatment Market
https://www.delveinsight.com/sample-request/catheter-related-bloodstream-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Scope of the Catheter Related Bloodstream Infections Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Catheter Related Bloodstream Infections Companies: CorMedix, Xellia Pharmaceuticals Ltd., Pfizer, Glenmark Pharmaceuticals Ltd., Fresenius Medical Care, CorMedix, Inc., TauroPhar GmbH, Geistlich Pharma, Citus Pharmaceuticals, AstraZeneca, Merck & Co., Inc., and others
• Key Catheter Related Bloodstream Infections Therapies: DEFENCATH, Mino-Lok, Neutrolin, Daptomycin, Linezolid, and others
• Catheter Related Bloodstream Infections Therapeutic Assessment: Catheter Related Bloodstream Infections current marketed and Catheter Related Bloodstream Infections emerging therapies
• Catheter Related Bloodstream Infections Market Dynamics: Catheter Related Bloodstream Infections market drivers and Catheter Related Bloodstream Infections market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Catheter Related Bloodstream Infections Unmet Needs, KOL's views, Analyst's views, Catheter Related Bloodstream Infections Market Access and Reimbursement
To know more about Catheter Related Bloodstream Infections companies working in the treatment market, visit @ Catheter Related Bloodstream Infections Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/catheter-related-bloodstream-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Catheter Related Bloodstream Infections Market Report Introduction
2. Executive Summary for Catheter Related Bloodstream Infections
3. SWOT analysis of Catheter Related Bloodstream Infections
4. Catheter Related Bloodstream Infections Patient Share (%) Overview at a Glance
5. Catheter Related Bloodstream Infections Market Overview at a Glance
6. Catheter Related Bloodstream Infections Disease Background and Overview
7. Catheter Related Bloodstream Infections Epidemiology and Patient Population
8. Country-Specific Patient Population of Catheter Related Bloodstream Infections
9. Catheter Related Bloodstream Infections Current Treatment and Medical Practices
10. Catheter Related Bloodstream Infections Unmet Needs
11. Catheter Related Bloodstream Infections Emerging Therapies
12. Catheter Related Bloodstream Infections Market Outlook
13. Country-Wise Catheter Related Bloodstream Infections Market Analysis (2020-2034)
14. Catheter Related Bloodstream Infections Market Access and Reimbursement of Therapies
15. Catheter Related Bloodstream Infections Market Drivers
16. Catheter Related Bloodstream Infections Market Barriers
17. Catheter Related Bloodstream Infections Appendix
18. Catheter Related Bloodstream Infections Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Catheter Related Bloodstream Infections Pipeline https://www.delveinsight.com/report-store/catheter-related-bloodstream-infection-crbsi-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Catheter Related Bloodstream Infections Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Catheter Related Bloodstream Infections market. A detailed picture of the Catheter Related Bloodstream Infections pipeline landscape is provided, which includes the disease overview and Catheter Related Bloodstream Infections treatment guidelines.
Catheter Related Bloodstream Infections Epidemiology https://www.delveinsight.com/report-store/catheter-related-bloodstream-infection-crbsi-epidemiology-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Catheter Related Bloodstream Infections Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Catheter Related Bloodstream Infections epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
• Implantable Cardioverter Defibrillators Market: https://www.delveinsight.com/report-store/defibrillator-market
• Monkeypox Market: https://www.delveinsight.com/report-store/monkeypox-market
• Antibody Drug Conjugate Market: https://www.delveinsight.com/report-store/antibody-drug-conjugate-market
• Healthcare Competitive Benchmarking: https://www.delveinsight.com/consulting/competitive-benchmarking-services
• Tbi Market: https://www.delveinsight.com/report-store/traumatic-brain-injury-market
• Indwelling Catheters Market: https://www.delveinsight.com/report-store/indwelling-catheters-market
• Hyperlipidemia Market: https://www.delveinsight.com/report-store/hyperlipidemia-market
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Catheter Related Bloodstream Infections Market Predicted to See Upsurge Through 2034, Highlights DelveInsight | Xellia Pharma, Pfizer, Glenmark Pharma, Fresenius Medical Care here
News-ID: 3954770 • Views: …
More Releases from DelveInsight Business Research
Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals.
Objective of the Case Study
The…
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics.
According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than…
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies.
Biopsy devices play a crucial role in disease diagnosis by…
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide.
DelveInsight's General Surgery Devices Market Report 2032 provides…
More Releases for Catheter
Midline Catheter Market
The midline catheter market plays a crucial role in healthcare, providing a safer and more effective means for intravenous (IV) therapies. Midline catheters are long, thin, flexible tubes that are inserted into a patient's veins, typically for periods ranging from a few days to a few weeks. They offer a minimally invasive alternative for administering medications, fluids, and nutrients directly into the bloodstream without the need for repeated needle sticks.…
Catheter Stabilization Devices Market
The "Catheter Stabilization Devices Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Catheter Stabilization Devices Market, 2024-2031
Verified Market Research's most recent report, "Catheter Stabilization Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides…
Catheter Stabilization Devices Market: Enhancing Patient Safety and Care through …
The Catheter Stabilization Devices Market occupies a pivotal position in the healthcare industry, providing essential solutions for securing catheters and enhancing patient care. As indwelling catheters become integral to various medical procedures and treatment protocols, the need for effective stabilization and securement is paramount. This market addresses this crucial requirement by offering a diverse range of devices designed to prevent catheter-related complications, including dislodgement and infection.
𝗧𝗼 𝗮𝗰𝗰𝗲𝘀𝘀 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗺𝗮𝗿𝗸𝗲𝘁…
Catheter Introducer Sheaths Market - Safeguarding Vascular Health: Advanced Shea …
Newark, New Castle, USA: The "Catheter Introducer Sheaths Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Catheter Introducer Sheaths Market: https://www.growthplusreports.com/report/catheter-introducer-sheaths-market/8787
This latest report researches the industry structure,…
Catheter-related Blood Infections Market - Empowering Catheter Safety: Leading t …
Newark, New Castle, USA: The "Catheter-related Blood Infections Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Catheter-related Blood Infections Market: https://www.growthplusreports.com/report/catheterrelated-blood-infections-market/8671
This latest report researches the industry structure,…
Exclusive Report on Catheter Stabilization Devices Catheter Securement Devices M …
According to the study published by Evolve business intelligence, “The global Catheter Stabilization Devices Catheter Securement Devices market size is expected to reach $ Billion by 2028 growing at the CAGR of 15% from 2021 to 2028. The report provides the reader with a deep-dive understanding of business opportunities, competitor analysis, market size and forecast, go-to-market strategy, and market share. After evaluating the next-gen business analytic report, the reader is…
